Cinnarizine Impurity B is a structurally related byproduct arising from the alkylation step in cinnarizine synthesis, characterized by a substituted ethyl group on the piperazine nitrogen and an extended methylene bridge connecting the phenothiazine core. Its molecular architecture retains the tricyclic phenothiazine scaffold but exhibits a modified side chain with reduced steric hindrance compared to the parent drug. This impurity serves as a critical HPLC reference standard for quantifying process-derived deviations in cinnarizine active pharmaceutical ingredient (API) batches.
On RequestC1CN(CCN1C/C=C\C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10-
DERZBLKQOCDDDZ-RAXLEYEMSA-N